Robert Martin Grotzfeld

This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Novartis Ag. Active years: 2014-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Martin Grotzfeld. Retrieved from https://idiyas.com/inventor/robert-martin-grotzfeld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 4)

% Patents Active = 85.7

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 9.5

ph-index = 3

Forward Citations = 16(Granted Patents)

Company Filing History:

7 out of 3,977

Novartis Ag

patents

Years Active: 2014-2018

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9896444 - Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 (2018-02-20),

2. 9498540 - Cell proliferation inhibitors and conjugates thereof (2016-11-22),

3. 9458112 - Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 (2016-10-04),

4. 9340537 - Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 (2016-05-17),

5. 9315489 - Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 (2016-04-19),

6. 9278981 - Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 (2016-03-08),

7. 8829195 - Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 (2014-09-09),

I specialize in innovations, inventions, and patents. If you have any questions related to this field, feel free to ask!

Profile summary based on public USPTO records.